Medicare Enrolled

Dr. Arnold Blaustein, M.D.

Optician · Miami Beach, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
4306 ALTON RD, Miami Beach, FL 33140
3055353305
In practice since 2005 (20 years)
NPI: 1497743124 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Blaustein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Blaustein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Blaustein

Dr. Arnold Blaustein is an optician in Miami Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Blaustein performed 359 Medicare services across 106 unique beneficiaries.

Between the years covered by Open Payments, Dr. Blaustein received a total of $29,883 from 84 pharmaceutical and/or device companies across 1247 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Blaustein is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ 359 Medicare services$ $29,883 industry payments

Medicare Practice Summary

Medicare Utilization ↗
359
Medicare services
Bottom 21% in FL for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
106
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~18 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)347$52$165
New patient office visit (45-59 min)12$94$433
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$29,883
Total received (2018-2024)
Avg $4,269/year across 7 years
Top 6% in FL for optician
84
Companies
1,247
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,590 (68.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,529 (28.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$764 (2.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,605
2023
$2,470
2022
$10,403
2021
$2,036
2020
$1,639
2019
$5,341
2018
$5,390

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Kite Pharma, Inc.
$5,917
Gilead Sciences, Inc.
$2,985
Celgene Corporation
$1,728
AstraZeneca Pharmaceuticals LP
$1,536
Novartis Pharmaceuticals Corporation
$1,458
Janssen Biotech, Inc.
$1,309
Genentech USA, Inc.
$1,219
PFIZER INC.
$1,143
EMD Serono, Inc.
$1,136
Merck Sharp & Dohme Corporation
$917
E.R. Squibb & Sons, L.L.C.
$732
Amgen Inc.
$650
Incyte Corporation
$579
Astellas Pharma US Inc
$578
Lilly USA, LLC
$493
Takeda Pharmaceuticals U.S.A., Inc.
$415
Daiichi Sankyo Inc.
$390
Merck Sharp & Dohme LLC
$334
Eisai Inc.
$307
BeiGene USA, Inc.
$297
Pharmacyclics LLC, An AbbVie Company
$278
Boehringer Ingelheim Pharmaceuticals, Inc.
$273
Janssen Pharmaceuticals, Inc
$241
Sumitomo Pharma America, Inc.
$233
AbbVie Inc.
$221
Bayer HealthCare Pharmaceuticals Inc.
$219
GENZYME CORPORATION
$215
Clovis Oncology, Inc.
$214
Seagen Inc.
$197
Ipsen Biopharmaceuticals, Inc
$197
Epizyme, Inc.,
$163
ABBVIE INC.
$162
Exelixis Inc.
$147
Regeneron Healthcare Solutions, Inc.
$141
TESARO, Inc.
$128
MorphoSys, US Inc.
$123
Karyopharm Therapeutics Inc.
$111
Myriad Genetic Laboratories, Inc.
$105
Teva Pharmaceuticals USA, Inc.
$104
Sun Pharmaceutical Industries Inc.
$103
Deciphera Pharmaceuticals Inc.
$102
EUSA Pharma (US) LLC
$94
Dova Pharmaceuticals
$92
MEDIVATION FIELD SOLUTIONS LLC
$87
Aurobindo Pharma USA, Inc.
$82
TAIHO ONCOLOGY, INC.
$79
Bayer Healthcare Pharmaceuticals Inc.
$74
Kyowa Kirin, Inc.
$73
Myovant Sciences Inc.
$72
Seattle Genetics, Inc.
$69
Spectrum Pharmaceuticals Inc.
$64
Pharmacyclics LLC, an AbbVie Company
$64
Mirati Therapeutics, Inc.
$63
AVEO Pharmaceuticals, Inc.
$60
JAZZ PHARMACEUTICALS INC.
$60
Dendreon Pharmaceuticals LLC
$60
AbbVie, Inc.
$60
Helsinn Therapeutics (U.S.), Inc.
$59
Adaptive Biotechnologies Corporation
$58
AMAG Pharmaceuticals, Inc.
$58
EISAI INC.
$56
Foundation Medicine, Inc.
$53
CTI BioPharma Corp.
$52
Rigel Pharmaceuticals, Inc.
$50
Acceleron Pharma, Inc.
$50
Genmab U.S., Inc.
$46
Shire North American Group Inc
$42
SpringWorks Therapeutics, Inc.
$41
ADC Therapeutics America, Inc.
$41
SOBI, INC
$40
SANOFI-AVENTIS U.S. LLC
$35
Agios Pharmaceuticals, Inc.
$27
Epizyme, Inc.
$25
TerSera Therapeutics LLC
$24
Janssen Scientific Affairs, LLC
$21
SERVIER PHARMACEUTICALS LLC
$20
Alexion Pharmaceuticals, Inc.
$19
Midatech Pharma US Inc
$19
Tempus AI, Inc
$18
Taiho Oncology, Inc.
$18
Stemline Therapeutics Inc.
$16
Medtronic USA, Inc.
$15
Verastem, Inc.
$15
Otsuka America Pharmaceutical, Inc.
$13
Top 3 companies account for 35.6% of total payments
Associated products mentioned in payments ›
ABSORICA · ADCETRIS · AKEEGA · AKYNZEO · ALIMTA · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BENDEKA · BOSULIF · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMEND · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · Enhertu · Epkinly · Erleada · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Folotyn · GAZYVA · GILOTRIF · Gelclair · Halaven · IBRANCE · ICLUSIG · ILUMYA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lupron · Lupron Depot · MEKINIST · MONJUVI · MVASI · MYLOTARG · MYRISK · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · ONUREG · OPDIVO · ORGOVYX · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RYDAPT · Reblozyl · Revlimid · Rituxan Hycela · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNCHROMED · Stivarga · Sylvant · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · ULTOMIRIS · VELCADE · VENCLEXTA · VERZENIO · VOTRIENT · VPRIV · VYXEOS · Venclexta · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (69%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for optician in FL.

Equivalent to $8,324 per 100 Medicare services performed
Looking for a optician in Miami Beach?
Compare opticians in the Miami Beach area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
711
Per 100K population
26.5
County median income
$68,694
Nearest hospital
MOUNT SINAI MEDICAL CENTER OF FLORIDA, INC
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Blaustein is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 6%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Blaustein experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Blaustein performed 347 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Blaustein receive payments from pharmaceutical companies?
Yes. Dr. Blaustein received a total of $29,883 from 84 companies across 1,247 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Blaustein's costs compare to other opticians in Miami Beach?
Dr. Blaustein's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Blaustein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →